When Your Weight Loss Has Plateaued, the Phone Cannot Adjust the Dose
There is a particular kind of phone call where the right answer is “no, but here is why, and here is what to do next”. In 21 years of general practice, the calls of this shape are the ones that need the most care. An adult patient on a GLP-1 weight management injection at the established starter dose called the out-of-hours line, citing a weight loss plateau, and asking for a dose escalation. The clinical answer was that a dose change of this medication category cannot safely be made on a phone call. The pastoral answer was to explain why, in plain language, and to set up the right next step.
The plateau, and why it is normal
Weight loss on a GLP-1 weight management injection is rarely linear. The first weeks often see rapid loss as appetite suppression takes effect and caloric intake reduces. The body then adjusts. Basal metabolic rate slows in proportion to weight loss. Reduced muscle mass means slightly fewer calories burned at rest. Adaptive thermogenesis sets in. The result is a plateau, often somewhere between weeks 8 and 16, that is a normal physiological feature of the weight loss curve, not a sign that the medication has stopped working. Knowing that the plateau is normal does not make it less frustrating. It does make the next step more rational.
There are several reasons a plateau happens on this medication category, and dose insufficiency is only one of them. Adherence may have drifted, the injection may be missed once a week here, once a fortnight there, and the clinical effect tracks adherence closely. Injection technique may have slipped, the wrong site, the wrong angle, leaking after withdrawal. Compensatory eating may have crept in, often unconsciously, as appetite suppression eases over time. Underlying endocrine factors may have changed, thyroid, blood sugar, stress hormones. True dose insufficiency is genuine, but it is one possibility among several. Distinguishing them requires more than a phone call.
Clinical anomaly: what was almost missed
First, what was almost missed. Saying “yes” to a dose escalation on a phone call, without reviewing why the plateau has happened, would have been the wrong answer. The clinical question is not “is the dose too low?” The clinical question is “why has the trajectory changed?” Adherence, technique, eating pattern, and underlying physiology all need to be checked before a dose change is made. A phone call cannot do that work. A dose increase made without that work is not a personalised step forward; it is a guess, and a guess on a medication category that has known side effects is the wrong default.
Second, where the standard NHS pathway would have gone. The standard out-of-hours response would have been a polite refusal, followed by “see your GP”. The deviation today was to explain, in plain terms, why the face-to-face is needed and what the appointment will actually cover. Patients on a weight management medication category need partners in the work, not gatekeepers. The conversation in the call sets the tone for the next visit. NICE NG246 frames the management of obesity in primary care, including the role of pharmacological options alongside lifestyle modification, and the structured review at appointment is the right setting for that integration.
Third, what differentials were ruled out. The differentials here are not clinical, they are pathway. Out-of-hours dose change is unsafe; the right setting is a face-to-face routine appointment, with time to review adherence, technique, dietary pattern, and recent monitoring bloods. Once those are reviewed, the question of dose change becomes a clinical question with an answer. Ruling out adherence drift, technique drift, and compensatory eating is not a paperwork exercise. It is the essential work that turns “the dose is too low” into a true statement, if it is true.
What a structured weight management review actually does
A structured review at a same day private GP appointment for someone on a GLP-1 weight management injection is, in practice, four pieces of work in one slot. The first piece is adherence and injection technique. When was the last dose taken? How often have doses been missed in the last 4 to 8 weeks? Is the technique still correct? Are there any storage issues with the device? The second piece is dietary review. A 7-day food diary is gold; a 24-hour recall is the next best. The reviewer is not looking for failure. The reviewer is looking for the patterns the patient has stopped noticing.
The third piece is monitoring. Recent bloods within the last 3 to 6 months, including kidney function, liver function, thyroid function where relevant, and glycaemic markers. Pancreatitis features asked about directly. Any new gastrointestinal symptoms beyond the expected. The fourth piece is the dose decision, made in context. If adherence is excellent, technique is correct, eating pattern is well understood, monitoring is reassuring, and the plateau is sustained beyond what is physiologically expected, then a dose escalation discussion is appropriate. If any of those is not the case, the dose escalation discussion is not yet appropriate. That is what the structured review buys.
Why “see your GP” is not enough
“See your GP” is the right pathway. It is not, on its own, a useful thing to say to a patient who is already calling at 9pm because the weight loss has stalled and the next routine appointment is two weeks away. The patient needs more than a referral back. The patient needs an explanation of why the answer is what it is, what the appointment will look like, what to bring (the food diary, the injection log, the questions written down), and a sense that the call has been useful in itself. That is the pastoral content of a triage call.
Same day private GP access at Clinique Alpa includes that triage conversation. The decision not to change a dose on a phone call is a clinical decision. The way the decision is communicated is also a clinical decision. Both matter.
What to bring to a face-to-face plateau review
Three things make the appointment 80 percent more useful. First, a 7-day food and drink diary, recorded honestly, including snacks, drinks, and weekend variation. The reviewer is not judging; the reviewer is reading the patterns. Second, the injection log, with the dates of each dose, any missed doses, and any side effects noted. Third, a short list of questions written down before the appointment. Plateaus produce questions. Writing them down before the appointment is the difference between a 15 minute appointment that resolves the questions and a 15 minute appointment that runs over time on the same questions returning.
When to see a same day private GP for a weight loss medication concern
Several thresholds should move a patient towards a same day private GP appointment for a weight management concern rather than waiting it out. A plateau lasting more than 4 to 8 weeks. New gastrointestinal symptoms beyond the expected first weeks. Any new severe abdominal pain, particularly radiating to the back, which needs to be reviewed urgently. Any new persistent vomiting. Any sense that the medication is not behaving as it did initially. Any concerns about technique, dose, or storage that have not been addressed at a previous review. The point of the same day appointment is the structured review, the time, and the right next step.
What Clinique Alpa offers
Same day access. Live record review. Structured weight management review with time for the four pieces of work above. Honest conversations about the limits of phone consultations and what they should be used for. Practical preparation for the appointment, including the food diary and the injection log. No prescription only medicine names in our public writing, by the rule. The plan in the room is the plan, and the plan does not include changing a dose without the structured review that makes the change safe and sensible.
Read more on this theme on our pillar page: Same Day Private GP, Palmers Green.
Clinique Alpa. Same day private GP, Palmers Green, North London.